Home/Filings/4/0001562180-25-004355
4//SEC Filing

Fox Allan M. 4

Accession 0001562180-25-004355

CIK 0001590877other

Filed

Jun 2, 8:00 PM ET

Accepted

Jun 3, 4:37 PM ET

Size

10.8 KB

Accession

0001562180-25-004355

Insider Transaction Report

Form 4
Period: 2025-05-30
Fox Allan M.
Director
Transactions
  • Award

    Stock Options (Right to Buy)

    2025-05-30+39,81539,815 total
    Exercise: $8.85Exp: 2035-05-30Common Stock (39,815 underlying)
  • Award

    Common Stock

    2025-05-30+7,76819,054 total
Holdings
  • Common Stock

    (indirect: By LLC)
    1,529,981
  • Common Stock

    (indirect: By Trust)
    722,485
  • Common Stock

    (indirect: By Trust)
    315,000
  • Common Stock

    (indirect: By Trust)
    315,000
Footnotes (3)
  • [F1]Represents shares of common stock underlying a time-based restricted stock unit award (RSU). 100% of the shares subject to this RSU will vest on May 1, 2026 subject to the continuous service of the recipient to the Issuer.
  • [F2]The reporting person disclaims beneficial ownership of such shares except to the extent of his indirect pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
  • [F3]The option will vest in 12 equal monthly installments following May 30, 2025 subject to the continuous service of the optionee to the Issuer.

Issuer

REGENXBIO Inc.

CIK 0001590877

Entity typeother

Related Parties

1
  • filerCIK 0001652936

Filing Metadata

Form type
4
Filed
Jun 2, 8:00 PM ET
Accepted
Jun 3, 4:37 PM ET
Size
10.8 KB